The volume oj distribution oj amikacin and the APACHE II score were determined in 42 critically ill patients being treated jor a gram-negative injection. The mean volume oj distribution (Vd!) was 0041 ± 0.12 IIkg with a wide range (normal oj 0.25 IIkg). There was a good relationship between the Vdt and illness severity as measured by the APACHE II score (r=0.70; P< 0.001). Critically ill patients should receive larger loading doses oj aminoglycosides in order to achieve therapeutic blood levels. The aminoglycoside Vdt may be usejul in determining the degree oj capillary leak and tissue oedema that accompanies sepsis.
Critically ill patients with sepsis offer unique challenges in drug dosing because of the pathophysiological changes that accompany sepsis. 1 The hepatic and renal clearance of drugs is often impaired, the protein binding decreased and the volume of distribution of many drugs is increased. 1 Sepsis results in a diffuse microcirculatory injury with endothelial damage and tissue oedema. '4The increased extracellular fluid increases the volume of distribution of drugs such as aminoglycosides, which are poorly protein bound. ' H We hypothesised that the severity of illness as determined by the APACHE II score might correlate with the increase in extracellular fluid as measured by the aminoglycoside volume of distribution.
PATIENTS AND METHODS
This study was conducted in a tertiary care intensive care unit (lCU). The study protocol was approved by the institutional review board for research involving human subjects. Patients over the age of 18 years, admitted to the ICU with a documented gram-negative infection, in whom treatment with an aminoglycoside antibiotic was indicated, were included in this study. Patients with a serum creatinine greater than 120 {tmolll were excluded from the study. A loading dose of 20 mg/kg of amikacin was given followed by a single daily dose of 15 mg/kg, adjusted to achieve predetermined blood levels. H.'! The aminoglycoside was given as a slow intravenous push-in over two to three minutes. H,'! A detailed pharmacokinetic study was done following the loading dose. Blood was drawn from an arterial line at 10, 20, 30, 40 minutes, and 1, 2, 4, 8, 12 and 24 hours. The aminoglycoside samples were assayed using an enzyme-linked immuno-assay (EMIT). The coefficient of variation was less than 10% for both control and interbatch samples. The lower limit of sensitivity for the assay was 0.1 {tg/ml. Serum amikacin concentration-time data were analysed using a nonlinear least squares regression analysis computer program assuming a two-compartment pharmacokinetic model (Nonlin). 8 The volume of the central compartment (VI), peripheral compartment (V2) and total volume of distribution (Vdt) were calculated for each patient. The APACHE II score, a widely utilised severity of illness scoring system, was used to quantify the severity of illness of the patients on admission to the ICU. 10 At the end of the data collection, summary statistics were compiled to allow a description of the study population. All data are expressed as the mean ± standard deviation. The relationship between the Vdt and APACHE 11 score was analysed by linear regression.
RESULTS
The pharmacokinetic profile of 42 patients was studied. The mean age of the patients was 34 ± 12.4 years and the mean serum creatinine 93.3 ± 31.2 {tmolll. The total volume of distribution (Vdt) of amikacin was 0.41 ± 0.12 IIkg (0.24-0.62). The mean APACHE II score was 12.6 ± 4.7. The correlation coefficient between the APACHE II score and the Vdt was 0.70 (P=O.OOl). The scatterplot of Vdt and APACHE II score is shown in Figure 1 . 
DISCUSSION
The outcome of gram-negative sepsis treated with an aminoglycoside antibiotic has been shown to depend on achieving adequate levels of the drug in the blood and tissues. 9
• 12 A number of studies have shown that when critically ill patients are treated with standard dosages of an aminoglycoside antibiotic the serum levels are often subtherapeutic. s. 9 The subtherapeutic levels are a consequence of the increased volume of distribution of aminoglycosides in the septic patient. s. 9 The mean Vdt of amikacin of 0.41 lIkg in this study is significantly larger than the value of 0.25 lIkg in healthy volunteers. 13 Consequently, a larger loading dose of aminoglycosides is required, in the critically ill patient, in order to rapidly achieve therapeutic blood levels. The sicker the patient the larger the loading dose that should be used. In addition patients may benefit from a single large daily dose of aminoglycoside. 9 Aminoglycoside antibiotics are highly charged drugs which are minimally protein bound, insoluble in lipids and have a volume of distribution similar to that of the extra-cellular space. 13 The volume of distribution of these drugs can therefore be used to indirectly measure the size of the extra-cellular compartment in septic patients.
Sepsis results in a diffuse microcapillary injury with endothelial damage and interstitial tissue oedema. H The increased Vdt of aminoglycoside antibiotics in the septic patient is largely due to the tissue oedema which accompanies sepsis. 2.8 In this study the increased volume of distribution of amikacin paralleled the severity of illness, as determined by the APACHE 11 score.
Anaesthesia and Intensive Care, Vol. 21. No. 2, April, 1993 Fuchs and colleagues have demonstrated intrapatient changes in the volume of distribution of aminoglycoside antibiotics. 14 After commencing therapy with an aminoglycoside these authors demonstrated a reduction in the Vdt, presumably reflecting an improvement in the microcapillary leak with a reduction in tissue oedema.
In summary, the extra-cellular fluid compartment in septic patients, as measured by the aminoglycoside Vdt, is increased in parallel to the severity of illness. The Vdt is dynamic, changing with the patients' clinical condition. The dosage strategy of aminoglycosides should take these changes into account. Furthermore the volume of distribution of aminoglycosides may be useful to indirectly quantitate the degree of capillary leak and interstitial oedema in septic patients.
